Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eli Lilly

780.67
+1.390.18%
Post-market: 780.00-0.6700-0.09%16:58 EDT
Volume:1.45M
Turnover:1.13B
Market Cap:739.87B
PE:66.67
High:783.55
Open:780.46
Low:773.00
Close:779.28
Loading ...

Eli Lilly Price Target Maintained With a $936.00/Share by Guggenheim

Dow Jones
·
20 Jun

Market Chatter: Lilly to Appeal Against UK Regulator's Recommendation Not to Reimburse Cost of Alzheimer's Drug

MT Newswires Live
·
20 Jun

This AI Trader Bought Meta Stock and Dumped Eli Lilly -- Barrons.com

Dow Jones
·
20 Jun

BRIEF-EMA's CHMP Re-Examines Rejection Of Kisunla For Early Alzheimer’S Treatment

Reuters
·
20 Jun

Ema's Chmp: Started Re-Examination of Its March 2025 Recommendation Not to Grant a Marketing Authorisation for Kisunla on June 2

THOMSON REUTERS
·
20 Jun

Eli Lilly says India response to obesity drug Mounjaro is 'positive', will focus on meeting demand

Reuters
·
20 Jun

Eli Lilly (LLY) to Offer Higher Doses of Its Weight-Loss Drug on Website

TIPRANKS
·
20 Jun

Eli Lilly: to Appeal National Institute for Health and Care Excellence's ‘No’ for Donanemab (Kisunla) in UK's National Health Service

THOMSON REUTERS
·
19 Jun

Eli Lilly: Remains Confident in Clinical Efficacy and Cost-Effectiveness of Donanemab

THOMSON REUTERS
·
19 Jun

Eli Lilly (LLY) Enters Gene-Editing Space with Verve Therapeutics Acquisition

TIPRANKS
·
19 Jun

UBS Sticks to Its Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
18 Jun

Scholar Rock's Drug Helps Patients on Zepbound Preserve Muscle in Trial

Reuters
·
18 Jun

Hold Rating on Verve Therapeutics Acquisition by Eli Lilly: Fair Valuation with Low Competing Bid Potential

TIPRANKS
·
18 Jun

Health Rounds: Weight-loss surgery more effective than drugs in real world study

Reuters
·
18 Jun

Sector Update: Health Care Stocks Fall in Afternoon Trading

MT Newswires Live
·
18 Jun

Deals of the day-Mergers and acquisitions

Reuters
·
17 Jun

Eli Lilly Shares Down 1.8%

THOMSON REUTERS
·
17 Jun

Lilly to Buy Gene-Editing Partner Verve for up to $1.3 Billion in Cardiac Care Push

Reuters
·
17 Jun

Eli Lilly & Co (LLY) Receives a Buy from Citi

TIPRANKS
·
17 Jun

BRIEF-Lilly To Acquire Verve Therapeutics To Advance One-Time Treatments For People With High Cardiovascular Risk

Reuters
·
17 Jun